Bioequivalence and patient satisfaction with a growth hormone (Saizen®) needle-free device - Results of clinical and laboratory studies

Today's Therapeutic Trends

Volumn 18, Issue 1, 2000, Pages 71-86

  Murray, F T ^a   Silverstein, J H ^a   Johnson, S B ^a   Gertner, J H ^a   Frye, K ^a   Gironda, G ^a   Wang, Q ^a   Stene, M ^a  

^a EMD SERONO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG INCOMPATIBILITY; DRUG SAFETY; GROWTH HORMONE DEFICIENCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JET INJECTION; NEEDLESTICK INJURY; PAIN ASSESSMENT; PATIENT SATISFACTION;

EID: 0034117863     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)